These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11599972)

  • 1. Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study.
    Wong E; Bennett S; Lawrence B; Fauconnier T; Lu LF; Bell RA; Thornback JR; Eshima D
    Inorg Chem; 2001 Oct; 40(22):5695-700. PubMed ID: 11599972
    [No Abstract]   [Full Text] [Related]  

  • 2. A CD(4)/T(4) receptor peptide ligand labeled with technetium-99m: synthesis and biological activity.
    Boschi A; Uccelli L; Bolzati C; Marastoni M; Tomatis R; Spisani S; Traniello S; Piffanelli A
    Nucl Med Biol; 2000 Nov; 27(8):791-5. PubMed ID: 11150712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes.
    Green AE; Causey PW; Louie AS; Armstrong AF; Harrington LE; Valliant JF
    Inorg Chem; 2006 Jul; 45(15):5727-9. PubMed ID: 16841972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
    Hayne DJ; White JM; McLean CA; Villemagne VL; Barnham KJ; Donnelly PS
    Inorg Chem; 2016 Aug; 55(16):7944-53. PubMed ID: 27459001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. '2+1' tricarbonyltechnetium(I)/tricarbonylrhenium(I) mixed-ligand complexes with methyl thiosalicylate and isocyanide ligands as potential precursors of radiopharmaceuticals.
    Koźmiński P; Gniazdowska E; Fuks L; Kowalska S
    Appl Radiat Isot; 2011 Feb; 69(2):436-42. PubMed ID: 21129987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of rhenium and technetium-99m labeled insulin.
    Sundararajan C; Besanger TR; Labiris R; Guenther KJ; Strack T; Garafalo R; Kawabata TT; Finco-Kent D; Zubieta J; Babich JW; Valliant JF
    J Med Chem; 2010 Mar; 53(6):2612-21. PubMed ID: 20235598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. '2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.
    Fuks L; Gniazdowska E; Kozminski P; Lyczko M; Mieczkowski J; Narbutt J
    Appl Radiat Isot; 2010 Jan; 68(1):90-5. PubMed ID: 19766012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
    Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
    Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
    Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
    Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picolylamine-methylphosphonic acid esters as tridentate ligands for the labeling of alcohols with the fac-[M(CO)3]+ core (M = 99mTc, Re): synthesis and biodistribution of model compounds and of a 99mTc-labeled cobinamide.
    Mundwiler S; Waibel R; Spingler B; Kunze S; Alberto R
    Nucl Med Biol; 2005 Jul; 32(5):473-84. PubMed ID: 15982578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.
    Zhen W; Han H; Anguiano M; Lemere CA; Cho CG; Lansbury PT
    J Med Chem; 1999 Jul; 42(15):2805-15. PubMed ID: 10425090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous synthesis of derivatized cyclopentadienyl complexes of technetium and rhenium directed toward radiopharmaceutical application.
    Bernard J; Ortner K; Spingler B; Pietzsch HJ; Alberto R
    Inorg Chem; 2003 Feb; 42(4):1014-22. PubMed ID: 12588133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the best N(3-) donors in preparation of [M(N)(PNP)]-based (M=(99m)Tc-; (188)Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ).
    Carta D; Jentschel C; Thieme S; Salvarese N; Morellato N; Refosco F; Ruzza P; Bergmann R; Pietzsch HJ; Bolzati C
    Nucl Med Biol; 2014 Aug; 41(7):570-81. PubMed ID: 24909864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
    Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
    J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the labeling of two novel RGD-peptidic derivatives with the precursor [99mTc(H2O)3(CO)3]+ and evaluation for early angiogenesis detection in cancer.
    Psimadas D; Fani M; Zikos C; Xanthopoulos S; Archimandritis SC; Varvarigou AD
    Appl Radiat Isot; 2006 Feb; 64(2):151-9. PubMed ID: 16099668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of technetium-99m-labeled bioreductive pharmacophores conjugated with amino acids and peptides for tumor imaging.
    Baishya R; Nayak DK; Karmakar S; Chattopadhyay S; Sachdeva SS; Sarkar BR; Ganguly S; Debnath MC
    Chem Biol Drug Des; 2015 Apr; 85(4):504-17. PubMed ID: 25243793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against Glut 1 and hexokinase.
    Schibli R; Dumas C; Petrig J; Spadola L; Scapozza L; Garcia-Garayoa E; Schubiger PA
    Bioconjug Chem; 2005; 16(1):105-12. PubMed ID: 15656581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
    Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
    Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.
    Stephenson KA; Banerjee SR; Sogbein OO; Levadala MK; McFarlane N; Boreham DR; Maresca KP; Babich JW; Zubieta J; Valliant JF
    Bioconjug Chem; 2005; 16(5):1189-95. PubMed ID: 16173797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.